Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AbbVie fails to woo Shire, but investors think someone can do it
Marketwatch
Friday, June 20, 2014 - 11:22am
tags:
AbbVie, Shire, M&A
Imminent District Court Ruling Should Propel Zogenix Higher
Seeking Alpha
Friday, June 20, 2014 - 11:21am
tags:
Zogenix, Zoydro
Surging Earnings Estimates Signal Good News for Endocyte (ECYT)
Yahoo/Zacks.com
Friday, June 20, 2014 - 11:03am
tags:
earnings, Endocyte
Protalix Drug in Phase IIa Study for Gaucher Disease
Yahoo/Zacks.com
Friday, June 20, 2014 - 11:02am
tags:
Protalix BioTherapeutics, Gaucher disease, PRX-112
Merck begins tender offer to acquire Idenix
The Fly on the Wall
Friday, June 20, 2014 - 9:41am
tags:
Merck, Idenix, M&A
FDA asks for wider warning on testosterone products
Yahoo/Reuters
Friday, June 20, 2014 - 9:41am
tags:
FDA, testosterone, AbbVie, Endo Health Solutions
AbbVie - Attempt To Acquire Shire Is Driven By Opportunistic Tax Synergies
Seeking Alpha
Friday, June 20, 2014 - 9:40am
tags:
AbbVie, Shire, taxes, M&A
IPO Preview: Kite Pharma
Seeking Alpha
Friday, June 20, 2014 - 9:39am
tags:
IPOs, Kite Pharma, cancer immunotherapy
3 Key Opportunities for Medtronic and Covidien
Motley Fool
Friday, June 20, 2014 - 9:37am
tags:
Medtronic, devices, emerging markets, Covidien
AbbVie Offered $46.5 Billion for Shire as Bid Rejected
Bloomberg
Friday, June 20, 2014 - 9:36am
tags:
Shire, AbbVie, M&A
Will Allergan scramble for Shire to beat off Valeant's hostile advance?
Fierce Pharma
Thursday, June 19, 2014 - 5:47pm
tags:
Allergan, Shire, Valeant Pharmaceuticals, M&A
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
Thursday, June 19, 2014 - 5:47pm
tags:
NUVIGIL, patents, Teva Pharmaceuticals, Sandoz, Apotex, Mylan Labs, Actavis, Lupin
Isis Could Get a $2 Billion Gain From Heart Attack Trials
Bloomberg
Thursday, June 19, 2014 - 5:44pm
tags:
heart attack, Isis Pharmaceuticals, ISIS-APOCIIIRx
Is Pfizer Putting the Car-T Before the Horse?
Motley Fool
Thursday, June 19, 2014 - 5:43pm
tags:
Pfizer, CAR-T, Cellectis
Cubist Readies For Takeoff With New Antibiotic Launch
Investors.com
Thursday, June 19, 2014 - 5:39pm
tags:
antibiotics, Cubist Pharmaceuticals, Sivextro
The Case For and Against Valeant Pharmaceuticals
Motley Fool
Thursday, June 19, 2014 - 11:38am
tags:
Valeant Pharmaceuticals, M&A, Allergan
15 Highest-Paid Biopharma CEOs of 2013
Fierce Pharma
Thursday, June 19, 2014 - 11:36am
tags:
executive pay
FDA takes on Twitter and other online etiquette for medtech makers
Mass Device
Thursday, June 19, 2014 - 11:08am
tags:
FDA, social media, devices
Dr. Reddy’s to Invest in Biologics, Proprietary Medicines
Bloomberg
Thursday, June 19, 2014 - 11:07am
tags:
Dr Reddy's, India
Study: Suicides rise in wake of 'black box' warnings on antidepressants
Fierce Pharma
Thursday, June 19, 2014 - 10:55am
tags:
antidepressants, suicide, black box

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.